Science and Research

WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease. IPF is characterized by epithelial cell injury and reprogramming, increases in (myo)fibroblasts, and altered deposition of extracellular matrix. The Wnt1-inducible signaling protein 1 (WISP1) is involved in impaired epithelial-mesenchymal crosstalk in pulmonary fibrosis. Here, we aimed to further investigate WISP1 regulation and function in primary human lung fibroblasts (phLFs). We demonstrate that WISP1 is directly upregulated by Transforming growth factor beta1 (TGFbeta1) and Tumor necrosis factor alpha (TNFalpha) in phLFs, using a luciferase-based reporter system. WISP1 mRNA and protein secretion increased in a time- and concentration-dependent manner by TGFbeta1 and TNFalpha in phLFs, as analysed by qPCR and ELISA, respectively. Notably, WISP1 is required for TGFbeta1- and TNFalpha-dependent induction of interleukin 6 (IL-6), a mechanism that is conserved in IPF phLFs. The siRNA-mediated WISP1 knockdown led to a significant IL-6 reduction after TGFbeta1 or TNFalpha stimulation. Furthermore, siRNA-mediated downregulation or antibody-mediated neutralization of WISP1 reduced phLFs proliferation, a process that was in part rescued by IL-6. Taken together, these results strongly indicate that WISP1-induced IL-6 expression contributes to the pro-proliferative effect on fibroblasts, which is likely orchestrated by a variety of profibrotic mediators, including Wnts, TGFbeta1 and TNFalpha.

  • Klee, S.
  • Lehmann, M.
  • Wagner, D. E.
  • Baarsma, H. A.
  • Konigshoff, M.

Keywords

  • CCN Intercellular Signaling Proteins/genetics/*metabolism
  • Cell Proliferation/drug effects
  • Cells, Cultured
  • Fibroblasts/*cytology/drug effects/*metabolism
  • Humans
  • Interleukin-6/*metabolism
  • Lung/*cytology
  • Models, Biological
  • Promoter Regions, Genetic/genetics
  • Proto-Oncogene Proteins/genetics/*metabolism
  • Pulmonary Fibrosis/metabolism/pathology
  • Signal Transduction/drug effects
  • Transforming Growth Factor beta1/pharmacology
  • Tumor Necrosis Factor-alpha/pharmacology
Publication details
DOI: 10.1038/srep20547
Journal: Sci Rep
Pages: 20547 
Work Type: Original
Location: CPC-M
Disease Area: DPLD
Partner / Member: HMGU
Access-Number: 26867691
See publication on PubMed


chevron-down